Jafron
Jafron
Jianfan Bio is a developer of biomaterials and medical devices
Jianfan Bio is a developer of biomaterials and medical devices, specializing in blood purification products as its main business.
- All
- News
- Analysis
- Research
Briefing Sep 30, 2021 02:41 PM
· Healthcare
AstraZeneca acquires Caelum Biosciences overweight rare diseases business
Briefing Sep 27, 2021 11:57 AM
· Healthcare
Triarm therapeutics completed a round of financing of US $60 million
In depth
Briefing Sep 15, 2021 09:15 AM
· Healthcare
Huihe medical completed round B + financing and focused on building a whole industry platform for cardiovascular intervention
Briefing Sep 13, 2021 09:21 AM
· Healthcare
Xushui Internet obtained tens of millions of yuan pre-A round of financing to accelerate the research and development of medical equipment aiot and digital applications
Apr 22, 2021 03:11 PM
Research
Consumer Staples, Technology, HealthcareWIA2020 | Rising Tech Stars 2020: Global & China's 100
Dec 09, 2020 09:57 AM
Dec 09, 2020 09:39 AM
Aug 09, 2020 12:23 AM
Briefing Aug 31, 2021 05:29 PM
· Healthcare
Dashi pharmaceutical completed a round of financing of nearly 100 million yuan
Briefing Aug 31, 2021 01:54 PM
· Healthcare
Shanghai Songli biology led the formulation of ASTM International Standards for the first time
Briefing Aug 30, 2021 10:24 AM
· Healthcare
Xinhua biological vibrantfold can accurately predict the antibody structure in 1 minute
Insight
Briefing Aug 18, 2021 09:37 AM
· Healthcare
Yiying medical obtained 65 million yuan of a + round financing to accelerate the expansion of intraoperative 3D imaging equipment product line
Briefing Aug 05, 2021 09:08 PM
· Healthcare
Beijing builds a global digital economy highland, and ander medical wisdom biomind helps release the potential of digital economy
Briefing Jul 31, 2021 06:23 PM
· Healthcare
GE Healthcare and Tsinghua Industrial Research Institute landed on the health science and technology innovation platform G ² Chuang · Center
Healthcare
Sinopharm COVID Vaccine Receives WHO Emergency Use Certification
The Sinopharm Group’s COVID Vaccine is the sixth vaccine to receive safety, efficacy and quality verification from the World Health Organization (WHO). It is the first vaccine from a non-Western country to receive WHO certification.
May 11, 2021 03:35 AM
Healthcare
Yunnan Baiyao's Revenue Rises 33%; Net Profit Falls 40% in 1Q 2021
On April 27, Yunnan Baiyao released a report for the first quarter of 2021 showing that the company's total operating revenue for the first quarter was 10.33 billion yuan, up 33.4% year-on-year; its operating profit was 880 million yuan, down 41.8% year-on-year; its net profit attributable to shareholders of the listed company was 760 million yuan.
Apr 30, 2021 02:07 AM
Briefing Jul 30, 2021 09:36 AM
· Healthcare
Sox medical, a developer of clinical digital medical sensors, won hundreds of millions of yuan in round C financing
Briefing Jul 30, 2021 09:23 AM
· Healthcare
Daxiang technology obtained tens of millions of yuan of a + round financing to accelerate the layout of organ chip industry chain and technical iteration
Briefing Jul 26, 2021 09:15 AM
· Healthcare
Focusing on innovative Neurointerventional medical devices, Yike medical completed nearly 100 million yuan of round a financing
See more
Related Companies
EqualOcean Analysis
- Black Swans and Breakthroughs: China's Top 50 Innovative Public Firms in 2020
- More Room for the Medical Device Market to Grow in China
- Chinese CT Big Brother Neusoft Eyes the Booming Star Market
- Top 10 Market Cap Chinese Medical Device Companies: Champions and Runners-Up
- YuYue Medical Devices: Not Too Late to Focus on R&D
EqualOcean is an information service provider and investment research company that aims to become a global platform for industrial innovation. Founded in February 2014 and headquartered in Beijing, with a client network covering over 50 countries, the firm provides comprehensive professional services, including industry research, investment analysis, innovation consulting, data products, corporate branding and international strategy.